BIRD Health Act of 2025

This bill would set up a United States–Israel health innovation program, called the BIRD Health Program, to help develop and deliver medical products and services to people who need them. It funds joint projects by companies, universities, and health groups in areas like medical devices, medicines and biologics, telemedicine and digital health, artificial intelligence for care, vaccines, and disease tracking. It also backs stronger telemedicine systems, secure data sharing, and disease prevention. The program encourages U.S.-based manufacturing for biologic medicines and plans to prevent supply shortages by building more reliable supply chains. “Health technology” here includes medical devices, drugs, digital health tools, AI-driven diagnostics, and biologics.

The bill allows $10 million each year from 2026 through 2032 for these projects. The government has 180 days to set up the program plan, and then within a year it must start taking proposals. The program must share results every year and get a full review every three years to check progress and make improvements.

• Who is affected: Patients; U.S. and Israeli researchers, startups, and health providers; U.S. sites that make biologic medicines.
• What changes: New funding for joint research and real-world use of health tools; stronger telemedicine and data sharing; vaccine and disease prevention work; steps to build secure, U.S.-based biologics manufacturing and avoid shortages.
• When: Funding runs 2026–2032; program plan due in 180 days; proposals accepted within one year after the plan is set; yearly updates and a review every three years.